Cone-Beam Computed Tomography (CBCT) Market Predicted to Achieve Exceptional 11.7% CAGR Growth Until 2030

The global Cone Beam Computed Tomography (CBCT) Market, as revealed by Next Move Strategy Consulting, exhibited a valuation of USD 1.33 billion in 2022 and is poised to surge to USD 3.45 billion by 2030, boasting a Compound Annual Growth Rate (CAGR) of 11.7% from 2023 to 2030.

The ever-increasing prevalence of dental diseases and the widespread adoption of digital dentistry practices on a global scale are the driving forces propelling this market's growth.

Moreover, the utility of Cone Beam Computed Tomography (CBCT) is not limited to dentistry but has been extending into various medical applications. This expansion includes its use in fields such as orthopedics, lung cancer diagnosis, and the detection of brain tumors, which has been a significant driver for its growth. CBCT has proven to be an invaluable tool in these diverse medical domains, providing healthcare professionals with the ability to obtain comprehensive and highly precise visualizations of affected areas within the human body.

For those interested, a sample can be requested here: https://www.nextmsc.com/cbct-systems-market/request-sample

In orthopedics, CBCT technology has revolutionized diagnostic capabilities by offering three-dimensional imaging of bone structures. This enables orthopedic specialists to better assess fractures, joint alignments, and other musculoskeletal conditions with enhanced accuracy. The detailed visualizations aid in treatment planning and surgical procedures, ultimately improving patient outcomes.

In the context of lung cancer diagnosis, CBCT plays a pivotal role in providing rapid and accurate imaging of the chest area. The technology's ability to swiftly capture three-dimensional images with advanced 3D capabilities is invaluable for identifying lung nodules and other abnormalities associated with the disease. This expedites the diagnostic process, allowing healthcare professionals to promptly initiate treatment, potentially increasing the chances of successful outcomes for patients.

Similarly, in the realm of brain tumor detection, CBCT has become a critical tool for neurologists and neurosurgeons. By offering comprehensive 3D visualizations of the brain, CBCT assists in precisely locating and assessing tumors. This information is vital for surgical planning, as it allows for more precise and minimally invasive procedures, reducing potential risks and enhancing the overall quality of care for patients.

For example, CurveBeam has introduced the innovative bilateral weight-bearing CT imaging solution, HiRise, which provides precise 3D images of the hip joint in a weight-bearing position, thereby enhancing diagnostic accuracy and orthopedic patient care.

Philips, a renowned global leader in medical technology, is at the forefront of advancing the use of Cone Beam Computed Tomography (CBCT) for the detection and treatment of lung cancer. Their pioneering efforts have led to the introduction of a groundbreaking 3D CT X-ray system, a cutting-edge innovation that promises to revolutionize the way lung cancer is diagnosed and managed.

This revolutionary 3D CT X-ray system from Philips is a true game-changer in the field of medical imaging. It seamlessly combines the high-speed capabilities of traditional CT scans with state-of-the-art 3D imaging technology. The result is a powerful diagnostic tool that is specially tailored to expedite the diagnosis of lung cancer.

The key strength of this innovative solution lies in its exceptional precision and accuracy. It has been meticulously designed to detect even the tiniest of lung nodules and abnormalities associated with the disease. By offering such high levels of accuracy, it significantly enhances the efficiency of the lung cancer diagnosis process.

This advancement is particularly significant because it addresses a critical aspect of patient care. Timely and accurate diagnosis is a crucial factor in the effectiveness of any medical treatment, and lung cancer is no exception. The ability to swiftly and precisely identify lung cancer-related issues means that healthcare professionals can initiate treatment plans promptly.

By reducing the time it takes to diagnose and begin treatment, the Philips 3D CT X-ray system ultimately improves patient outcomes and enhances the overall quality of care provided to those affected by lung cancer. This cutting-edge technology empowers healthcare providers to offer timely and effective interventions, potentially increasing the chances of successful treatment and recovery for patients.

Moreover, the rising adoption of CBCT for diagnosing brain tumors is further stimulating market growth. Companies like Hitachi provide Proton Therapy System PROBEAT Series and Heavy-ion Therapy System HyBEAT for brain cancer diagnosis.

Inquiry regarding purchase can be made here: https://www.nextmsc.com/cbct-systems-market/inquire-before-buying

However, concerns regarding radiation exposure and the complex regulatory environment governing CBCT scans, which varies from one country to another, are acting as restraints to market expansion. On the flip side, the integration of Artificial Intelligence (AI) into CBCT software has the potential to improve image analysis, automate tasks, and simulate treatment outcomes, ultimately leading to more effective treatment planning and personalized patient care, thus creating opportunities for the CBCT market.

The report offers an exhaustive segmentation of the CBCT market based on patient position, detector type, field of view, application, end user, and region. The global CBCT market is classified into seated, supine, and standing based on patient position.

For detector type, the market is divided into image intensifiers and flat-panel detectors. The field of view is categorized into small FOV systems, medium FOV systems, and large FOV systems. In terms of application, the market covers dental, ENT applications, orthopedic conditions, neural & spine, lung cancer, and veterinary.

The end-user segment includes dental clinics, hospitals, and others. Regionally, the report divides the market into North America, Europe, Asia-Pacific, and the rest of the world (RoW).

The presence of key players in the Asia-Pacific region, such as Hefei Meyer Optoelectronic Technology Inc, LargeV Instrument Corp., Vatech Co., Ltd, Genoray Co. Ltd, and others, is driving industry growth. These companies are actively engaged in various business strategies, including product development, marketing, and distribution, making CBCT more accessible and affordable to healthcare providers in the region.

For instance, LargeV Instrument Corp. Ltd. launched its innovative Ultra3D dual-source ENT CBCT system, approved by the National Medical Products Administration (NMPA) in China for X-ray inspections in Ear Nose Throat (ENT), stomatology, and maxillofacial surgery applications in October 2022.

Additionally, the aging population in countries like Japan, South Korea, and China, which are more susceptible to oral and orthopedic diseases, is further propelling market growth. The rise in the proportion of citizens aged 60 and above in China is projected to significantly increase the diagnosis of various dental diseases, thereby boosting the demand for CBCT applications in the region.

North America is expected to witness substantial CBCT market growth in the coming years, driven by increased government initiatives focusing on dental health and high healthcare expenditure in the region.

Moreover, frequent product launches by regional players such as Dentsply Sirona, Curve Beam AI, Dexis LLC, and others are set to further bolster the market. Dexis LLC, for example, recently announced the launch of a new intraoral scanning portfolio designed to cater to different clinical needs and preferences, enhancing accuracy, ease of use, and advanced features for dental professionals, thereby streamlining workflows and improving treatment planning and outcomes.

Customization options for the reports are available here: https://www.nextmsc.com/services

The report offers an in-depth analysis of major market players operating in the CBCT market, including Dentsply Sirona, Koninklijke Philips N.V., Vatech Co., Ltd., Dexis LLC, Planmeca OY, J. Morita Mfg. Corp., Cefla S.C., Hefei Meyer Optoelectronic Technology, Inc., Xoran Technologies LLC, Acteon Group, and others. The report provides comprehensive insights into the competitive landscape.

Access Full Report: https://www.nextmsc.com/report/cbct-systems-market

Contact Us:

Next Move Strategy Consulting
Full Postal Address: 5th Floor, 867 BOYLSTON ST STE 500
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: www.nextmsc.com

About Us:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, dedicated to delivering high-quality market research reports that empower multinational companies to outperform their competitors and expand their industry presence by capturing a larger market share. Our research model is a unique blend of primary research, secondary research, data mining, and data analytics.

For over a decade, we have served more than 1,000 customers globally, including 90% of the Fortune 500 companies. Our analysts continually monitor various high-growth markets, identifying hidden opportunities in each sector or industry. We offer some of the industry's finest syndicated and custom research reports spanning 10 different industry verticals. We are committed to delivering high-quality research solutions tailored to your business requirements. Our industry-standard delivery solutions, from pre-consultation to after-sales services, provide an excellent client experience and ensure accurate strategic decision-making for businesses.

This release was published on openPR.